Hydrochloric Acid

Hydrochloric Acid

SCHEMBL822288

CC(C)CN(CC(C)C)[Nd+]N(CC(C)C)CC(C)C.[Cl-]

nearest known ligand 0.32

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.32
CA1 P00915 3/20 0.32
CA2 P00918 3/20 0.32
CA9 Q16790 3/20 0.32
CYP1A2 P05177 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL821919 0.93 CA12 (0.32) CA12CA1CA2CA9CYP1A2
Fluoride Ion SCHEMBL821757 0.93 CA12 (0.32) CA12CA1CA2CA9CYP1A2
Iodide SCHEMBL821874 0.93 CA12 (0.32) CA12CA1CA2CA9CYP1A2
Iodide SCHEMBL4551026 0.65 PIK3CD (0.33) CA12CA1CA2CA9CYP1A2
SCHEMBL21574005 0.62 CA12 (0.38) CA12CA1CA2CA9CYP1A2
SCHEMBL65000 0.62 CYP1A2 (0.53) CA12CA1CA2CA9CYP1A2
Hydrochloric Acid SCHEMBL27423371 0.62 CA12 (0.33) CA12CA1CA2CA9CYP1A2
Hydrochloric Acid SCHEMBL8599323 0.62 CA12 (0.33) CA12CA1CA2CA9CYP1A2
Hydrochloric Acid SCHEMBL8600072 0.62 CA12 (0.33) CA12CA1CA2CA9CYP1A2
SCHEMBL7940758 0.60 ALDH1A1 (0.35) CA12CA1CA2CA9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153545-B2 Process for homo—or copolymerization of conjugated olefins STYRON EUROPE GMBH (CH) 2012-04-10 US disclosed
US-20110160041-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS STYRON EUROPE GMBH 2011-06-30 US disclosed
US-7915194-B2 Process for homo- or copolymerization of conjugated olefins STYRON EUROPE GMBH (CH) 2011-03-29 US disclosed
EP-2267046-A1 Process for homo- or copolymerization of conjugated olefines DOW GLOBAL TECHNOLOGIES INC. (US) 2010-12-29 EP disclosed
US-20100248947-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-09-30 US disclosed
US-7612009-B2 Process for homo-or copolymerization of conjugated olefines DOW GLOBAL TECHNOLOGIES, INC. (US) 2009-11-03 US disclosed
US-20060142145-A1 Process for homo-or copolymerization of conjugated olefines TRINSEO EUROPE GMBH (CH) 2006-06-29 US disclosed
EP-1597292-A2 PROCESS FOR HOMO- OR COPOLYMERIZATION OF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES INC. (US) 2005-11-23 EP disclosed
WO-2004076504-A2 PROCESS FOR HOMO- OR COPOLYMERIZATION OF CONJUGATED OLEFINES DOW GLOBAL TECHNOLOGIES, INC. (US) 2004-09-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110160041-A1 PROCESS FOR HOMO - OR COPOLYMERIZATION OF CONJUGATED OLEFINS F12, ETFB, F2 CA12 1640/4885CA1 1312/4885CA2 1768/4885
US-20060142145-A1 Process for homo-or copolymerization of conjugated olefines ETFB, F12, F2 CA12 1903/4885CA1 1385/4885CA2 1844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.